• Users Online: 173
  • Home
  • Print this page
  • Email this page
RESEARCH ARTICLE
Year : 2020  |  Volume : 10  |  Issue : 3  |  Page : 103-109

Argon treatment after experimental subarachnoid hemorrhage: evaluation of microglial activation and neuronal survival as a subanalysis of a randomized controlled animal trial


1 Department of Neurosurgery, RWTH Aachen University Hospital, Aachen, Germany
2 Department of Anaesthesiology, RWTH Aachen University Hospital, Aachen, Germany
3 Institute of Neuropathology, RWTH Aachen University Hospital, Aachen, Germany

Correspondence Address:
Anke Höllig
Department of Neurosurgery, RWTH Aachen University Hospital, Aachen
Germany
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2045-9912.296039

Rights and Permissions

Hereinafter, we evaluate argon’s neuroprotective and immunomodulatory properties after experimental subarachnoid hemorrhage (SAH) examining various localizations (hippocampal and cortical regions) with respect to neuronal damage and microglial activation 6, 24 and 72 hours after SAH. One hour after SAH (endovascular perforation rat model) or sham surgery, a mixture of gas containing 50% argon (argon group) or 50% nitrogen (control group) was applied for 1 hour. At 6 hours after SAH, argon reduced neuronal damage in the hippocampal regions in the argon group compared to the control group (P < 0.034). Hippocampal microglial activation did not differ between the treatment groups over time. The basal cortical regions did not show a different lesion pattern, but microglial activation was significantly reduced in the argon group 72 hours after SAH (P = 0.034 vs. control group). Whereas callosal microglial activation was significantly reduced at 24 hours in the argon-treated group (P = 0.018). Argon treatment ameliorated only early hippocampal neuronal damage after SAH. Inhibition of microglial activation was seen in some areas later on. Thus, argon may influence the microglial inflammatory response and neuronal survival after SAH; however, due to low sample sizes the interpretation of our results is limited. The study protocol was approved by the Government Agency for Animal Use and Protection (Protocol number: TVA 10416G1; initially approved by the “Landesamt für Natur, Umwelt und Verbraucherschutz NRW,” Recklinghausen, Germany, on April 28, 2009).


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed428    
    Printed24    
    Emailed0    
    PDF Downloaded99    
    Comments [Add]    

Recommend this journal